Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Annals of the Rheumatic Diseases
|
January 21, 2009
Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion
Y Hou, B J Rabquer, M L Gerber, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 1, 1993
In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease
A E Koch, L B Kronfeld-Harrington, Z Szekanecz, et al.
Clinical Case Reports
|
August 17, 2021
Anemia in a young Guinean male
Nicholas S Wilcox, Chantal Tapé, Anthony J Cordisco, et al.
The Oncologist
|
May 13, 2022
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
Thomas B Karasic, Timothy J Brown, Charles Schneider, et al.
Nucleic Acids Research
|
July 14, 2016
S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells
Matthew J Warner, Katherine S Bridge, James P Hewitson, et al.
Journal of Dairy Science
|
May 21, 2013
Effects of lasalocid and intermittent feeding of chlortetracycline on the growth of prepubertal dairy heifers
R G Cabral, P S Erickson, N E Guindon, et al.
Cell
|
August 9, 2024
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8<sup>+</sup> T cells to promote antitumor immunity
Anthony R Cillo, Carly Cardello, Feng Shan, et al.
Frontiers in Oncology
|
July 22, 2022
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing <i>DPYD</i> and <i>UGT1A1</i> Screening to Guide Chemotherapy Dosing
Lisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma
Lilit Karapetyan, Anthony R Cillo, Shuaichao Wang, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Annals of the Rheumatic Diseases
|
January 21, 2009
Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion
Y Hou, B J Rabquer, M L Gerber, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 1, 1993
In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease
A E Koch, L B Kronfeld-Harrington, Z Szekanecz, et al.
Clinical Case Reports
|
August 17, 2021
Anemia in a young Guinean male
Nicholas S Wilcox, Chantal Tapé, Anthony J Cordisco, et al.
The Oncologist
|
May 13, 2022
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
Thomas B Karasic, Timothy J Brown, Charles Schneider, et al.
Nucleic Acids Research
|
July 14, 2016
S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells
Matthew J Warner, Katherine S Bridge, James P Hewitson, et al.
Journal of Dairy Science
|
May 21, 2013
Effects of lasalocid and intermittent feeding of chlortetracycline on the growth of prepubertal dairy heifers
R G Cabral, P S Erickson, N E Guindon, et al.
Cell
|
August 9, 2024
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8<sup>+</sup> T cells to promote antitumor immunity
Anthony R Cillo, Carly Cardello, Feng Shan, et al.
Frontiers in Oncology
|
July 22, 2022
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing <i>DPYD</i> and <i>UGT1A1</i> Screening to Guide Chemotherapy Dosing
Lisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma
Lilit Karapetyan, Anthony R Cillo, Shuaichao Wang, et al.
Page
of 7